Utilizing artificial neural networks to elucidate serum biomarker patterns which discriminate between clinical stages in melanoma

Proceedings of the 2005 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology, CIBCB '05

Volumn 2005, Issue , 2005, Pages

  Lancashire, Lee ^a   Ugurel, Selma ^b   Creaser, Colin ^a   Schadendorf, Dirk ^b   Rees, Robert ^a   Ball, Graham ^a  

^a NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^b Univeritatsklinkum Mannheim   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMARKERS; DATA MINING; PATIENT TREATMENT; PATTERN RECOGNITION; PROTEINS; TUMORS;

DIAGNOSTIC MARKERS; NOVEL PROGNOSTIC; TUMOR PROGRESSION;

NEURAL NETWORKS;

EID: 33847203996     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/cibcb.2005.1594954     Document Type: Conference Paper

References (24)

1. L.A. Liotta, E.C. Kohn, and E.F. Petricoin, "Personalized molecular medicine," JAMA, 286, pp.2211-2214, 2001.
2. E.F. Petricoin et al., "Use of proteomic patterns in serum to identify ovarian cancer," Lancet, 16:359, pp.572-577, 2002.
3. E.F. Petricoin, K.C. Zoon, E.C. Kohn, J.C. Barrett, and L.A. Liotta, "Clinical proteomics: translating benchside promise into bedside reality," Nat. Rev. Drug Discov., 9, pp.683-695, 2002.
4. E.F. Petricoin, and L.A. Liotta, "Mass spectrometry-based diagnostics: the upcoming revolution in disease detection," Clin. Chem., 49:4, pp.533-534, 2003.
5. R.C Krieg, N.T. Gaisa, C.P. Paweletz, and R. Knuechel, "Proteomic analysis of human bladder tissue using SELDI approach following microdissection techniques," Methods Mol. Biol., 293, pp.255-267, 2005.
6. L.E. Moore, et al., "Identification of biomarkers of arsenic exposure and metabolism in urine using SELDI technology," J. Biochem. Mol. Toxicol., 19:3, pp.176, 2005.
7. S. Das, et al., "Differential protein expression profiles of gastric epithelial cells following Helicobacter pylori infection using ProteinChips," J. Proteome. Res., 4:3, pp.920-930, 2005.
8. th European Simulation Multiconference, Nottingham, pp.131-135, 2003.
9. G. Ball, et al., "An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers," Bioinformatics, 18:3, pp.395-404, 2002.
10. S. Mian, et al., "A prototype methodology combining surface-enhanced laser desorption/ionization protein chip technology and artificial neural network algorithms to predict the chemoresponsiveness of breast cancer cell liner exposed to Paclitaxel and Doxorubicin under in vitro condition," Proteomics, 3, pp. 1725-1737, 2003.
11. L.J. Lancashire, S. Mian, I.O. Ellis, and R.C. Rees, "Current developments in the analysis of proteomic data: Artificial neural network data mining techniques for the identification of proteomic biomarkers related to breast cancer, Current Proteomics, 2, pp. 15-29, 2005.
12. L. Lancashire, O. Schmid, H. Shah, and G. Ball, "Classification of bacterial species from proteomic data using combinatorial approaches incorporating artificial neural networks, cluster analysis and principal components analysis," Bioinformatics, 21, pp.2191-2199, 2005.
13. S. Mian, et al, "Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients," J. Clin. Oncoogy., 23, pp.5088-5093, 2005.
14. A. Das. et al, "Prediction of outcome in acute lowergastrointestinal haemorrhage based on an artificial neural network; internal and external validation of a predictive model," Lancet, 362, pp. 1261-1266, 2003.
15. J. Khan, et al, "Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks," Nat. Med., 7, pp. 673-679, 2001.
16. J. T. Batuello, et al., "Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancer," Urology, 57, 481-485, 2001.
17. T. Anagnostou, et al, "Artificial neural networks for decision-making in urologic oncology," Eur. Urol., 43, 596-603.
18. C. Peterson, and M. Ringner, "Analyzing tumor gene expression profiles," Artif. Intell. Med., 28, 59-74, 2003.
19. G.R. Ball, et al., "Identification of non-linear influences on the seasonal ozone dose response of sensitive and resistant clover clones using artificial neural networks," Ecol. Model., 129, 153-168, 2000.
20. J. T. Wei, et al., "Understanding artificial neural networks and exploring their potential applications for the practicing urologist," Urology, 52, 161-172, 1998.
21. G. R. Balls, et al., "Towards unravelling the complex interactions between microclimate ozone dose and ozone injury in clover," Water Air Soil Poll., 85, 1467-1472, 1996.
22. C. Desilva, et al., "Artificial neural networks and breast-cancer prognosis," Aust. Comput. J., 26, 78-81, 1994.
23. D.E. Rumelhart, and J.L. McClelland, "Parallel distribution processing: Explorations in the microstructure of cognition, Volume 1: Foundations. MIT Press. Cambridge, MA, USA, 1986.
24. C.M. Bishop, "Neural Networks for Pattern Recognition," Oxford University Press Inc, New York, 1995.